Skip to main content
Log in

Smad3/4 Binding to Promoter II of P450arom So As to Regulate Aromatase Expression in Endometriosis

  • Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

Activin A can stimulate aromatase P450 (P450arom) expression in eutopic endometrial stromal cells (ESCs) of endometriosis by activin type I receptor-Smad pathway. In order to identify Smad3/4 binding to P450arom promoter II that mediates activin A response in ESCs, polymerase chain reaction (PCR) products of a serial truncated deletion of the P450arom promoter II region between —904 and +87 bp were inserted into the pGL3-basic vector to generate the promoter reporter plasmids. Luciferase reporter plasmids were cotransfected into cells with or without activin A (25 ng/mL). The pGL3 —705/+87 revealed a luciferase activity similar to pGL3 —904/+87, whereas progressive truncation to position —464/+87 and — 192/+87, the luciferase activity was significant variation. Chromatin immunoprecipitation assay and Smad4-small interfering RNA (siRNA) testify that Smad3/4 binds to the activin A-responsive aromatase promoter in ESCs. Chromatin immunoprecipitation assay-PCR assay demonstrated anti-Smad3 antibody complexes could interact with the amplified DNA of the activin A-responsive P450arom promoter. Mutations of the binding site (—141/— 138 bp, — 165/— 162 bp) in P450arom promoter II significantly reduced promoter activity of activin A fold-induction to 26% and 28%, respectively. We cotransfected pGL3 —705/+87 with control siRNA and Smad4-siRNA into ESCs in the presence of activin A. Luciferase analysis showed that Smad4-siRNA abolished increased promoter activity of activin A-induced P450arom expression. The effect of activin A on the p-Smad3 accumulation in the cytoplasm and nucleus was significantly abrogated following the pretreatment of ESCs with Smad4-siRNA. In conclusion, activated Smad3 proteins can bind to P450arom promoter —705/+87 bp region, responsive to activin A in ESCs, which can promote P450arom transcription.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schreinemacher MH, Backes WH, Slenter JM, et al. Towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging. PLoS One. 2012;7(3):e33241.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Barrier BF. Immunology of endometriosis. Clin Obstet Gynecol. 2010;53(2):397–402.

    Article  PubMed  Google Scholar 

  3. Ferrero S, Remorgida V, Maganza C, et al. Aromatase and endometriosis: estrogens play a role. Ann N Y Acad Sci. 2014;1317: 17–23.

    Article  CAS  PubMed  Google Scholar 

  4. Huhtinen K, Stahle M, Perheentupa A, Poutanen M. Estrogen biosynthesis and signaling in endometriosis. Mol Cell Endocrinol. 2012;358(2):146–154.

    Article  CAS  PubMed  Google Scholar 

  5. Marchais-Oberwinkler S, Wetzel M, Ziegler E, et al. New druglike hydroxyphenylnaphthol steroidomimetics as potent and selective 17beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseases. J Med Chem. 2011;54(2):534–547.

    Article  CAS  PubMed  Google Scholar 

  6. Rai P, Shivaji S. The role of DJ-1 in the pathogenesis of endometriosis. PLoS One. 2011;6(3):e18074.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Fedele L, Bianchi S, Zanconato G, Tozzi L, Raffaelli R. Gonadotropin-releasing hormone agonist treatment for endometriosis of the rectovaginal septum. Am J Obstet Gynecol. 2000;183(6):1462–1467.

    Article  CAS  PubMed  Google Scholar 

  8. Wolfler MM, Nagele F, Kolbus A, et al. A predictive model for endometriosis. Hum Reprod. 2005;20(6):1702–1708.

    Article  CAS  PubMed  Google Scholar 

  9. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996;81(1):174–179.

    CAS  PubMed  Google Scholar 

  10. Velasco I, Rueda J, Acien P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Mol Hum Reprod. 2006;12(6):377–381.

    Article  CAS  PubMed  Google Scholar 

  11. Huhtinen K, Desai R, Stahle M, et al. Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels. J Clin Endocrinol Metab. 2012;97(11):4228–4235.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kaneda H, Arao T, Matsumoto K, et al. Activin A inhibits vascular endothelial cell growth and suppresses tumour angiogenesis in gastric cancer. Br J Cancer. 2011;105(8):1210–1217.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Yoshino O, Izumi G, Shi J, et al. Activin-A is induced by interleukin-1beta and tumor necrosis factor-alpha and enhances the mRNA expression of interleukin-6 and protease-activated receptor-2 and proliferation of stromal cells from endometrioma. Fertil Steril. 2011;96(1):118–121.

    Article  CAS  PubMed  Google Scholar 

  14. Hirata T, Osuga Y, Takamura M, et al. Interleukin-17F increases the secretion of interleukin-8 and the expression of cyclooxygenase 2 in endometriosis. Fertil Steril. 2011;96(1):113–117.

    Article  CAS  PubMed  Google Scholar 

  15. Yoshino O, Hori M, Osuga Y, et al. Myomectomy reduces endometrial T2 relaxation times. Fertil Steril. 2011;95(8):2781–2783.

    Article  PubMed  Google Scholar 

  16. Wang Y, Libasci V, Bernard DJ. Activin A induction of FSHbeta subunit transcription requires SMAD4 in immortalized gonadotropes. J Mol Endocrinol. 2010;44(6):349–362.

    Article  CAS  PubMed  Google Scholar 

  17. Chen L, Zhang W, Liang HF, et al. Activin A induces growth arrest through a SMAD-dependent pathway in hepatic progenitor cells. Cell Commun Signal. 2014;12:18.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Woodruff TK, Mather JP. Inhibin, activin and the female reproductive axis. Annu Rev Physiol. 1995;57:219–44.

    Article  CAS  PubMed  Google Scholar 

  19. Risbridger GP, Schmitt JF, Robertson DM. Activins and inhibins in endocrine and other tumors. Endocr Rev. 2001;22(6):836–858.

    Article  CAS  PubMed  Google Scholar 

  20. Attisano L, Lee-Hoeflich ST. The Smads. Genome Biol. 2001; 2(8):REVIEWS3010.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Shi Y, Hata A, Lo RS, Massague J, Pavletich NP. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature. 1997;388(6637):87–93.

    Article  CAS  PubMed  Google Scholar 

  22. Zheng J, Qu J, Lu P, et al. Activin A stimulates aromatase via the ALK4-Smad pathway in endometriosis. Biomed Res Int. 2016; 2016:5791510.

    PubMed  PubMed Central  Google Scholar 

  23. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67(5):817–821.

    Article  Google Scholar 

  24. Hou Z, Zhou J, Ma X, Fan L, Liao L, Liu J. Role of interleukin-1 receptor type II in the pathogenesis of endometriosis. Fertil Steril. 2008;89(1):42–51.

    Article  CAS  PubMed  Google Scholar 

  25. Noble LS, Takayama K, Zeitoun KM, et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metabol. 1997;82(2):600–606.

    CAS  Google Scholar 

  26. Zeitoun K, Takayama K, Michael MD, Bulun SE. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol Endocrinol. 1999;13(2):239–253.

    Article  CAS  PubMed  Google Scholar 

  27. Simpson ER, Mahendroo MS, Means GD, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev. 1994;15(3):342–355.

    CAS  PubMed  Google Scholar 

  28. Chen SA, Besman MJ, Sparkes RS, et al. Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15. DNA. 1988;7(1):27–38.

    Article  CAS  PubMed  Google Scholar 

  29. Bulun SE, Sebastian S, Takayama K, Suzuki T, Sasano H, Shozu M. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters. J Steroid Biochem Mol Biol. 2003;86(3-5):219–224.

    Article  CAS  PubMed  Google Scholar 

  30. Harada N, Utsumi T, Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc Natl Acad Sci U S A. 1993; 90(23):11312–11316.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Harada N. A unique aromatase (P-450AROM) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts. Biochem Biophys Res Commun. 1992;189(2):1001–1007.

    Article  CAS  PubMed  Google Scholar 

  32. Sebastian S, Bulun SE. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. J Clin Endocrinol Metab. 2001;86(10):4600–4602.

    Article  CAS  PubMed  Google Scholar 

  33. Clyne CD, Speed CJ, Zhou J, Simpson ER. Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in pre-adipocytes. J Biol Chem. 2002;277(23):20591–20597.

    Article  CAS  PubMed  Google Scholar 

  34. Mahendroo MS, Mendelson CR, Simpson ER. Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J Biol Chem. 1993;268(26):19463–19470.

    Article  CAS  PubMed  Google Scholar 

  35. Zhou D, Chen S. Identification and characterization of a cAMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene. Arch Biochem Biophys. 1999;371(2):179–190.

    Article  CAS  PubMed  Google Scholar 

  36. Qiu Y, Krishnan V, Pereira FA, Tsai SY, Tsai MJ. Chicken ovalbumin upstream promoter-transcription factors and their regulation. J Steroid Biochem Mol Biol. 1996;56(1-6 Spec No):81–85.

    Article  CAS  PubMed  Google Scholar 

  37. Ritchie HH, Wang LH, Tsai S, O’Malley BW, Tsai MJ. COUP-TF gene: a structure unique for the steroid/thyroid receptor super-family. Nucleic Acids Res. 1990;18(23):6857–6862.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wang LH, Tsai SY, Cook RG, Beattie WG, Tsai MJ, O’Malley BW. COUP transcription factor is a member of the steroid receptor superfamily. Nature. 1989;340(6229):163–166.

    Article  CAS  PubMed  Google Scholar 

  39. Ladias JA, Karathanasis SK. Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor super-family. Science. 1991;251(4993):561–565.

    Article  CAS  PubMed  Google Scholar 

  40. Miyajima N, Kadowaki Y, Fukushige S, et al. Identification of two novel members of erbA superfamily by molecular cloning: the gene products of the two are highly related to each other. Nucleic Acids Res. 1988;16(23):11057–11074.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Zawel L, Dai JL, Buckhaults P, et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell. 1998;1(4):611–617.

    Article  CAS  PubMed  Google Scholar 

  42. Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, Whitman M. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature. 1997;389(6646):85–89.

    Article  CAS  PubMed  Google Scholar 

  43. Labbe E, Silvestri C, Hoodless PA, Wrana JL, Attisano L. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell. 1998;2(1):109–120.

    Article  CAS  PubMed  Google Scholar 

  44. Itoh S, Ericsson J, Nishikawa J, Heldin CH, ten Dijke P. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. Nucleic Acids Res. 2000;28(21):4291–4298.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Datto MB, Hu PP, Kowalik TF, Yingling J, Wang XF. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol Cell Biol. 1997;17(4):2030–2037.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhen Hou PhD, MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qu, J., Zhu, Y., Wu, X. et al. Smad3/4 Binding to Promoter II of P450arom So As to Regulate Aromatase Expression in Endometriosis. Reprod. Sci. 24, 1187–1194 (2017). https://doi.org/10.1177/1933719116681517

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/1933719116681517

Keywords

Navigation